Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01366352 · ClinicalTrials.gov registry record · Phase 1
Pharmacokinetics and Bioavailability Comparison of Two Different Formulations of MNTX Tablets
A Phase 1 study of Normal Volunteers, sponsored by Bausch Health Americas.
- Completed
- Registry status
- Phase 1
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT01366352 is a Phase 1 study of Normal Volunteers that has completed, run by Bausch Health Americas. The registered enrollment target is 24 participants, below the 1,457-participant average among 4 other Normal Volunteers trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01366352, a Phase 1 study of Normal Volunteers, has completed, sponsored by Bausch Health Americas.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
This was a single-center, double-blind, randomized, cross-over Phase 1 study in normal, healthy volunteers. Study treatment entailed single doses of two different formulations of MNTX tablets.
Conditions Studied
Interventions
- DRUG MNTX tablet (Formulation 1)
- DRUG MNTX tablet (Formulation 2)
Study Locations (1)
New York
- Progenics Pharmaceuticals, Inc. - Tarrytown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2004-02 |
| Est. Completion | 2004-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01366352
The ClinicalTrials.gov registry entry for NCT01366352 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,457-participant average among 4 other Normal Volunteers trials with a reported enrollment target (98% lower). The listed sponsor is Bausch Health Americas, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Normal Volunteers appearing as the primary indexed condition, and to 2 interventions - of which MNTX tablet (Formulation 1) is the first listed.
NCT01366352 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT01366352 about?
NCT01366352 is a clinical study titled "Pharmacokinetics and Bioavailability Comparison of Two Different Formulations of MNTX Tablets". This was a single-center, double-blind, randomized, cross-over Phase 1 study in normal, healthy volunteers. Study treatment entailed single doses of two different formulations of MNTX tablets.
What is the current status of trial NCT01366352?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2004-02. Estimated completion is 2004-03.
What conditions does trial NCT01366352 study?
This clinical trial studies the following conditions: Normal Volunteers.
What interventions are being tested in trial NCT01366352?
The interventions under investigation include: MNTX tablet (Formulation 1) (DRUG), MNTX tablet (Formulation 2) (DRUG).
Who is sponsoring clinical trial NCT01366352?
This trial is sponsored by Bausch Health Americas, which has 168 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01366352 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Normal Volunteers
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Safety, Tolerability and PK of ATTO-1310 in Healthy Volunteers and Patients With Atopic Dermatitis and Patients With Chronic Pruritus
ACTIVE NOT RECRUITING · Phase 1
-
Formulation Comparison in Normal Volunteers
COMPLETED · Phase 1
-
Tissue Procurement for Biomedical Research
RECRUITING
-
Studies of Dermatologic Diseases Biospecimen Acquisition Protocol
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.